Lmx4 Cream
NDC Package 0496-0882-71
Package Information
Lmx4 (lidocaine) cream is a medication used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). This formulation utilizes a cream delivery system. Marketed by Ferndale Laboratories, Inc., this product is identified by NDC 0496-0882 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1421893 - lidocaine 4 % Topical Cream
- RxCUI: 1421893 - lidocaine 40 MG/ML Topical Cream
- RxCUI: 1422103 - L-M-X-4 4 % Topical Cream
- RxCUI: 1422103 - lidocaine 40 MG/ML Topical Cream [LMX]
- RxCUI: 1422103 - LMX 40 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0496 - Ferndale Laboratories, Inc.
- 0496-0882 - Lmx4
- 0496-0882-71 - 1 TUBE in 1 BOX / 30 g in 1 TUBE (0496-0882-30)
- 0496-0882 - Lmx4
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0496-0882). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0496-0882-71 identifies a specific commercial package of 1 tube in 1 box / 30 g in 1 tube (0496-0882-30) of Lmx4, a human over the counter drug labeled by Ferndale Laboratories, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This cream is formulated for topical use and contains lidocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ferndale Laboratories, Inc. on January 03, 2011. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.
How is this Ferndale Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00496088271. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
